Royalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of “Buy” by Analysts
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the four brokerages that are covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have updated their coverage on the […]
More Stories
Optivise Advisory Services LLC Buys New Position in iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI)
Optivise Advisory Services LLC bought a new stake in shares of iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI – Free...
Great Valley Advisor Group Inc. Acquires 370,107 Shares of Janus Henderson AAA CLO ETF (NYSEARCA:JAAA)
Great Valley Advisor Group Inc. raised its holdings in shares of Janus Henderson AAA CLO ETF (NYSEARCA:JAAA – Free Report)...
JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST) Shares Purchased by Great Valley Advisor Group Inc.
Great Valley Advisor Group Inc. grew its position in shares of JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST – Free Report) by...
Flagstar Advisors Inc. Increases Stake in First Trust Senior Loan ETF (NASDAQ:FTSL)
Flagstar Advisors Inc. lifted its position in First Trust Senior Loan ETF (NASDAQ:FTSL – Free Report) by 5.7% in the...
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $16,440.78 in Stock
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,278 shares of the firm’s stock in a...
T-Mobile US, Inc. (NASDAQ:TMUS) Shares Acquired by First Horizon Advisors Inc.
First Horizon Advisors Inc. increased its stake in shares of T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) by 8.9% in...